Search Results - Wells Messersmith

ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways. by Surendra Singh, John Arcaroli, Ying Chen, David C Thompson, Wells Messersmith, Antonio Jimeno, Vasilis Vasiliou

Get full text

389 Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumo... by Laura Carter, Andrea Wang-Gillam, Johanna Bendell, Wungki Park, Wells Messersmith, Drew Rasco, Lei Zhou, Jean-Marie Bruey, Beatrice Ferguson, Jakob Dupont, Marya Chaney, Johann De Bono, David Nickle, Anna Galkin

344 Avelumab + binimetinib in metastatic pancreatic ductal adenocarcinoma (mPDAC): dose-escalation results from the phase 1b/2 JAVELIN PARP MEKi trial by Nathan Bahary, Sylvie Rottey, Wells Messersmith, Zhou Zhu, Jordi Rodon, Wael Harb, Daniel Weng Tan, Ignacio Garrido Laguna, J Thaddeus Beck, Shibing Deng, Karen Kowalski, Grainne O’Neill, Caimiao Wei, Nuzhat Pathan

Evorpacept plus rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma: results from the phase I ASPEN-01 study by Tae Min Kim, Nehal J. Lakhani, Jacob Soumerai, Manali Kamdar, Justin F. Gainor, Wells Messersmith, Philip Fanning, Shanhong Guan, Feng Jin, Alison Forgie, Hong I. Wan, Jaume Pons, Sophia S. Randolph, Won Seog Kim

Get full text

498 Evorpacept (ALX148), a CD47 myeloid checkpoint inhibitor, in patients with head and neck squamous cell carcinoma (HNSCC) and with gastric/gastroesophageal cancer (GC); ASPEN-01... by Tae Min Kim, Yung-Jue Bang, Keun-Wook Lee, Patricia LoRusso, Wells Messersmith, Feng Jin, Nehal Lakhani, Alison Forgie, Justin Gainor, Jaume Pons, Hong Wan, Pierre Squifflet, Laura Chow, Philip Fanning, Sophia Randolph, Hyun Chung, Rafael Santana-Davila, Won Seog Kim